| GLUE Average Annual Return Chart Since 2021 | |||
Also see: • GLUE stock yearly return 2022 • GLUE stock yearly return 2023 • GLUE stock yearly return 2024 • GLUE stock yearly return 2025 • GLUE YTD return | |||
| Average Annual Return Benchmarks |
|
Compare GLUE average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| GLUE Share Performance |
| GLUE Average Annual Return Table Since 2021 | ||||||||||||||||||||||||||||||
GLUE average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About Monte Rosa Therapeutics Inc |
| Monte Rosa Therapeutics, Inc. is a clinical-stage biotechnology company. Co. is engaged in developing a portfolio of novel and molecular glue degraders (MGDs) for patients living with serious diseases in the areas of oncology and autoimmune, and more. MGDs are small molecule drugs that employ the body's natural protein destruction mechanisms to selectively degrade therapeutically relevant proteins. It has developed a degradation platform, called Quantitative and Engineered Elimination of Neosubstrates (QuEEN) to enable its target centric MGD discovery and development approach and its rational design of MGD product candidates. The GLUE average annual return since 2021 is shown above.
The Average Annual Return on the GLUE average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether GLUE average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the GLUE average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| GLUE Current Stock Quote |
Quotes delayed 20 minutes  Free GLUE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| Monte Rosa Therapeutics (GLUE) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
GLXY Average Annual Return GMED Average Annual Return GNLX Average Annual Return GNMX Average Annual Return GNPX Average Annual Return GOSS Average Annual Return GOVX Average Annual Return GRCE Average Annual Return GRDN Average Annual Return GRDX Average Annual Return More Healthcare companies » |
Video: Don't Forget Dividends in Average Annual Return!